Trial · NCT06140836
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Progression-free Survival (PFS) as per Blinded Independent Central Review (BICR) according to Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 | Up to approximately 41 months | |
| Secondary | Overall Survival (OS) | Up to approximately 41 months | |
| Secondary | Overall Response Rate (ORR) as per BICR according to RECIST v1.1 | Up to approximately 41 months | |
| Secondary | ORR as per Investigator according to RECIST v1.1 | Up to approximately 41 months | |
| Secondary | Duration of Response (DOR) as per BICR according to RECIST v1.1 | Up to approximately 41 months | |
| Secondary | DOR as per Investigator according to RECIST v1.1 | Up to approximately 41 months | |
| Secondary | Time to Response (TTR) as per BICR according to RECIST v1.1 | Up to approximately 41 months | |
| Secondary | TTR as per Investigator according to RECIST v1.1 | Up to approximately 41 months | |
| Secondary | PFS as per Investigator according to RECIST v1.1 | Up to approximately 41 months | |
| Secondary | Time to intracranial progressions as per BICR according to RECIST v1.1 | Up to approximately 41 months | |
| Secondary | Number of participants with Adverse Events (AEs), Serious AEs (SAEs), AEs leading to study intervention discontinuation, and drug-related AEs | Up to 30 days after last dose | |
| Secondary | Number of deaths | Up to 30 days after last dose | |
| Secondary | Number of participants without at least a 3-point change in the Non-Small Cell Lung Cancer-Symptom Assessment Questionnaire (NSCLC-SAQ) total score | Up to 30 days after last dose |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06140836/registered